Suppr超能文献

[摩洛哥的乳腺癌:肿瘤的表型特征]

[Breast cancer in Morocco: phenotypic profile of tumors].

作者信息

Khalil Ahmadaye Ibrahim, Bendahhou Karima, Mestaghanmi Houriya, Saile Rachid, Benider Abdellatif

机构信息

Laboratoire de Physiopathologie et Génétique Moléculaire, Faculté des Sciences Ben M'Sik, Université Hassan II, Casablanca, Maroc.

Registre des Cancers de la Région du Grand Casablanca, Maroc.

出版信息

Pan Afr Med J. 2016 Oct 6;25:74. doi: 10.11604/pamj.2016.25.74.9966. eCollection 2016.

Abstract

Breast cancer is most common in women and it is among the leading causes of cancer related deaths. The curability of this type of tumor is increasing thanks to screening programs and treatment advances which have certainly enhanced patient survival. But challenges remain, particularly in respect of phenotypic instability of cancer cells. The aim of this study was to analyse the phenotypic profile of breast cancer in patients treated at Mohammed VI Cancer Treatment Center over the years 2013-2014. We conducted a cross-sectional study over a two-year period, including the cases of breast cancer treated in our Center. Data were collected from patients medical records and analyzed using Epi Info software. 1277 patients were treated in our Center. 99.5% were females, mean age 50.20 ± 11.34 years. The most common histological type was invasive ductal carcinoma (80.7% of cases). It was diagnosed at an early stage (56,9%). The most common molecular phenotype was luminal A (41.4% of cases). Luminal B, HER2 and triple negatives occurred in 10.4%, 6.3%, 11.2% of cases respectively. The study of tumor phenotype in patients with breast cancer helps clinician make treatment choice and policy makers implement programs against this disease.

摘要

乳腺癌在女性中最为常见,是癌症相关死亡的主要原因之一。由于筛查项目和治疗进展,这种类型肿瘤的治愈率正在提高,这无疑提高了患者的生存率。但挑战依然存在,尤其是癌细胞的表型不稳定性方面。本研究的目的是分析2013年至2014年在穆罕默德六世癌症治疗中心接受治疗的乳腺癌患者的表型特征。我们在两年期间进行了一项横断面研究,纳入了在我们中心接受治疗的乳腺癌病例。数据从患者病历中收集,并使用Epi Info软件进行分析。我们中心共治疗了1277例患者。其中99.5%为女性,平均年龄50.20±11.34岁。最常见的组织学类型是浸润性导管癌(占病例的80.7%)。其在早期被诊断出来(占56.9%)。最常见的分子表型是管腔A型(占病例的41.4%)。管腔B型、HER2型和三阴性分别占病例的10.4%、6.3%、11.2%。对乳腺癌患者肿瘤表型的研究有助于临床医生做出治疗选择,也有助于政策制定者实施针对这种疾病的项目。

相似文献

1
[Breast cancer in Morocco: phenotypic profile of tumors].
Pan Afr Med J. 2016 Oct 6;25:74. doi: 10.11604/pamj.2016.25.74.9966. eCollection 2016.
2
Pattern of breast cancer in a tertiary care center.
JNMA J Nepal Med Assoc. 2010 Jan-Mar;49(177):1-5.
3
[Breast cancer in men: about 40 cases and literature review].
Pan Afr Med J. 2017 Dec 4;28:287. doi: 10.11604/pamj.2017.28.287.13527. eCollection 2017.
4
[Epidemiological and anatomopathological profile of breast cancer at the Ibn Rochd University Hospital, Casablanca].
Pan Afr Med J. 2020 Sep 9;37:41. doi: 10.11604/pamj.2020.37.41.21336. eCollection 2020.
5
Breast cancer in Tunisia: clinical and pathological findings.
Asian Pac J Cancer Prev. 2011;12(1):169-72.
7
[Breast cancer in Cameroon, histo-epidemiological profile: about 3044 cases].
Pan Afr Med J. 2015 Aug 4;21:242. doi: 10.11604/pamj.2015.21.242.7269. eCollection 2015.
8
[Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca].
Pan Afr Med J. 2016 Oct 27;25:121. doi: 10.11604/pamj.2016.25.121.9967. eCollection 2016.
10
[Breast cancer in young patient in Morocco].
Gynecol Obstet Fertil. 2014 Mar;42(3):149-54. doi: 10.1016/j.gyobfe.2011.08.014. Epub 2012 Apr 20.

引用本文的文献

1
Breast cancer epidemiology and clinical outcomes in Moroccan women: a six-year retrospective study.
Pan Afr Med J. 2024 Dec 13;49:120. doi: 10.11604/pamj.2024.49.120.42588. eCollection 2024.
2
Breast cancer treatment and its impact on survival in Morocco: a study over a decade.
BMC Cancer. 2024 Jul 1;24(1):786. doi: 10.1186/s12885-024-12570-6.
5
Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression.
Bioengineered. 2022 Jan;13(1):291-307. doi: 10.1080/21655979.2021.2000724.
6
Male breast cancer: a report of 25 cases.
Pan Afr Med J. 2020 Dec 15;37:343. doi: 10.11604/pamj.2020.37.343.23004. eCollection 2020.
7
Breast cancer in togolese women: immunohistochemistry subtypes.
BMC Womens Health. 2020 Nov 23;20(1):261. doi: 10.1186/s12905-020-01130-2.

本文引用的文献

1
Triple-negative breast cancer.
N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389.
2
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
Cell Stem Cell. 2010 Sep 3;7(3):403-17. doi: 10.1016/j.stem.2010.07.010.
4
Breast cancer precursors revisited: molecular features and progression pathways.
Histopathology. 2010 Aug;57(2):171-92. doi: 10.1111/j.1365-2559.2010.03568.x. Epub 2010 May 24.
6
Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study.
Ultrastruct Pathol. 2009 Jul-Aug;33(4):141-50. doi: 10.1080/01913120903183135.
7
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
J Natl Cancer Inst. 2009 May 20;101(10):736-50. doi: 10.1093/jnci/djp082. Epub 2009 May 12.
9
Gene-expression signatures in breast cancer.
N Engl J Med. 2009 Feb 19;360(8):790-800. doi: 10.1056/NEJMra0801289.
10
Supervised risk predictor of breast cancer based on intrinsic subtypes.
J Clin Oncol. 2009 Mar 10;27(8):1160-7. doi: 10.1200/JCO.2008.18.1370. Epub 2009 Feb 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验